drugset / Trial / NCT01638689

A PET Study to Determine Alterations in Serotonin Levels in Human Brain After a Single Dose of Escitalopram

NCT01638689

Phase 1 Completed 10 enrolled Karolinska Institutet
NaSingle-groupOpen-labelBasic science

Summary

Healthy males were examined with positron emission tomography (PET) and the radioligand 11C-AZ10419369, before and after administration of a single dose escitalopram. A change in the binding potential of 11C-AZ10419369 between the baseline and the post-dose condition was hypothesized to reflect a change in serotonin concentration.

Timeline

Start
2010-09
Primary completion
2011-02
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 20 mg Oral

Indications

No indication recorded.